MedTrace Logo

The Effect of Orofacial Myofunctional Therapy With Autofeedback on Obstructive Sleep Apnea

NCT06079073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2025-04-01

No results posted yet for this study

Summary

The overall aim of this study is to estimate the effect of orofacial myofunctional therapy (OMT) plus auto-monitoring compared to auto-monitoring alone. Moreover, the investigators aim to identify anatomical and behavioural predictors of OMT adherence

Conditions

  • Sleep Apnea, Obstructive

Interventions

BEHAVIORAL

Orofacial myofunctional therapy with autofeedback

Participants opening a code unlocking the OMTa treatment module of the application will be given a direct communication link to the PhD students, Diana Hansen (Norway) and Andres Koster (Estonia) and two research co-ordinators. Dr. Hansen and Andres Köster has obtained an Academy of Orofacial Myofunctional Therapy (AOMT) certification diploma. One physical start up session will be scheduled at Ahus and at North Estonia Medical Center. This 60 minute session will be used to instruct participants in OMT exercises and use of the app. All participants will receive a disposable toothbrush and standardized balloons. After that, biweekly video sessions (time 20-30 min) will be scheduled.

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Oslo Metropolitan University

    collaborator OTHER

  • University of Tartu

    collaborator OTHER

  • Reykjavik University

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Harald Hrubos-Strøm, PhD · University Hospital, Akershus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-29
Primary Completion
2025-03-29
Completion
2025-03-29

Countries

  • Estonia
  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06079073 on ClinicalTrials.gov